Founded in 1986, Shire Pharmaceuticals Group plc is a rapidly growing international emerging pharmaceutical company with revenues for the full year 2002 of $1,037.3 million and an operating income of $327.038 million. The growth rates for revenues were 22% for 2002.
Shire intends to grow both organically and by acquisition. The business development team at Shire focuses on the 'search' aspect of the Search and Development strategy.
They are mainly involved in the acquisition of companies and in- and out-licensing of marketed products and development projects.
